The Next Generation Of Diagnostic Testing

Our proven technology empowers you to take control of your health at home

Lucira has developed a molecular or nucleic acid amplification test (NAAT) platform that provides accurate, at-home results for the detection of COVID-19 and flu viruses. Our self-tests have an analytical sensitivity (ability to detect viruses) that is comparable to some of the best performing PCR tests in clinical settings and high-complexity labs, at a fraction of the time.

To ensure the validity and accuracy of Lucira’s self-tests, several studies were conducted to compare our tests against highly sensitive PCR lab tests.

Learn more about our clinical studies